Work-up of the solitary pulmonary nodule

Abstract Although the solitary pulmonary nodule (SPN) is a common presentation of lung cancer, most SPNs are benign. The challenge in evaluating SPNs is to avoid invasive procedures in patients who have benign nodules, without allowing potentially curable bronchogenic carcinomas the time to progress to more advanced or even unresectable disease. Various approaches include assessment of nodule morphology, interval growth and contrast enhancement, as well as techniques such as percutaneous biopsy, positron emission tomography scanning and depreotide imaging. The role of each of these approaches is discussed.http://deepblue.lib.umich.edu/bitstream/2027.42/111300/1/40644_2015_Article_13.pd

Imaging as a guide to tissue sampling

http://deepblue.lib.umich.edu/bitstream/2027.42/117375/1/40644_2014_Article_30.pd

Image directed lymph node sampling for lung cancer staging

http://deepblue.lib.umich.edu/bitstream/2027.42/117374/1/40644_2014_Article_102.pd

Enhancing mediastinal mass at MR: Castleman disease

We report a case of an enhancing middle mediastinal mass imaged by MR and CT. Repeated nondiagnostic biopsies in this 25-yr-old male patient had resulted in profuse hemorrhage. Final pathological diagnosis after thoracotomy and debulking was Castleman disease. This is a rare, benign lymphoproliferative disorder of uncertain etiology. Histological varieties include the hyaline vascular type (80-90%) and the plasma cell type (10-20%). Cure is generally accomplished via surgical excision. This entity should be included in the differential diagnosis of enhancing mediastinal lesions, prompting awareness of the potential for bleeding complications following biopsy.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/31093/1/0000770.pd

Assessment of Radiologist Performance in the Detection of Lung Nodules

RATIONALE AND OBJECTIVES: Studies that evaluate the lung-nodule-detection performance of radiologists or computerized methods depend on an initial inventory of the nodules within the thoracic images (the “truth”). The purpose of this study was to analyze (1) variability in the “truth” defined by different combinations of experienced thoracic radiologists and (2) variability in the performance of other experienced thoracic radiologists based on these definitions of “truth” in the context of lung nodule detection on computed tomography (CT) scans. MATERIALS AND METHODS: Twenty-five thoracic CT scans were reviewed by four thoracic radiologists, who independently marked lesions they considered to be nodules ≥ 3 mm in maximum diameter. Panel “truth” sets of nodules then were derived from the nodules marked by different combinations of two and three of these four radiologists. The nodule-detection performance of the other radiologists was evaluated based on these panel “truth” sets. RESULTS: The number of “true” nodules in the different panel “truth” sets ranged from 15–89 (mean: 49.8±25.6). The mean radiologist nodule-detection sensitivities across radiologists and panel “truth” sets for different panel “truth” conditions ranged from 51.0–83.2%; mean false-positive rates ranged from 0.33–1.39 per case. CONCLUSION: Substantial variability exists across radiologists in the task of lung nodule identification in CT scans. The definition of “truth” on which lung nodule detection studies are based must be carefully considered, since even experienced thoracic radiologists may not perform well when measured against the “truth” established by other experienced thoracic radiologists

PET: other thoracic malignancies

The vast majority of esophageal cancers are fluorodeoxyglucose (FDG) avid; the primary use for positron emission tomography (PET) in patients with esophageal cancer is in the detection of distant metastases, because known distant metastatic disease precludes surgical resection. High standardized uptake values (SUVs) may be predictive of poor prognosis. PET findings may be used to assess therapy response and evaluate for esophageal tumor recurrence after treatment. PET findings may be non-specific in different types of thymic lesions, although thymic carcinomas tend to be extremely FDG avid. PET can be helpful in detecting distant spread from invasive thymomas and thymic carcinomas. Similarly, PET may be used to assess the extent of disease in patients with malignant pleural mesothelioma, thereby facilitating optimal therapy approaches

Lung cancer: assessing resectability

Staging classification in patients with non-small cell lung cancer does not always correlate perfectly with surgical resectability. Therefore, it is important to evaluate individual features of a patient’s tumor in order to determine if surgical resection is the optimal method of treatment, regardless of tumor stage. Such features include characteristics of the primary tumor, regional lymph nodes and distant sites

Imaging of anterior mediastinal masses

Multiple different types of anterior mediastinal masses may be encountered on computed tomography (CT) imaging, and many of these lesions are neoplastic in etiology. These include masses arising from the thymus, thyroid and parathyroid glands, as well as lymph nodes, pericardium, and vessels and nerves. Often, the CT attenuation of the mass can be helpful in narrowing down the differential diagnosis, and attenuation values suggesting fat, water or calcium may suggest certain diagnoses; significant enhancement of the mass with intravenous contrast may also be a helpful feature. Lesions with fatty attenuation include teratomas, thymolipomas and Morgagni hernias. Lesions that may manifest the attenuation of water include pericardial and thymic cysts, abscesses, and lymphangiomas, as well as neurogenic and germ cell tumors. Multiple types of lesions may contain calcium, including thyroid goiters and cancers, thymomas, thymic carcinomas and carcinoids, treated lymphoma, germ cell tumors, parathyroid adenomas, and lymph nodes involved with silicosis, sarcoid, tuberculosis, fungal diseases and pneumocystis. Contrast enhancement may be seen in lesions of vascular origin and in vascular neoplasms, such as parathyroid adenomas and Castleman's disease. In addition to CT attenuation values, the exact location and morphology of the mass in question, in conjunction with clinical features such as patient age, gender, signs, symptoms, and laboratory values, can usually lead to a short list of possible etiologies, thereby directing appropriate additional diagnostic procedures or therapeutic approaches

Staging work-up of patients with esophageal cancer

Accurate staging of disease in patients with newly diagnosed esophageal cancer is necessary in order to instigate appropriate curative or palliative therapy. The guidelines presented in this paper are suggested for the initial work-up of patients with newly diagnosed esophageal cancer, yet may be varied according to local preferences and availability of imaging technologies

Thoracic complications and emergencies in oncologic patients

Oncology patients often experience urgent or emergent medical complications that are a direct or indirect result of the underlying malignant condition and are first identified or clarified on radiologic imaging studies. The aim of this review is to identify, discuss, and illustrate some of the major thoracic complications in patients with primary intrathoracic or extrathoracic neoplasms; particular focus is placed on issues in which radiologic imaging may have a significant impact on patient management, including superior vena cava (SVC) syndrome, post-obstructive pneumonia, diaphragmatic paralysis, pleural effusions, pericardial disease, tracheo-esophageal fistula, deep venous thrombosis, and pulmonary embolism